Around 10 million new cases of dementia are diagnosed globally every year, with Alzheimer’s disease accounting for 60-70% of ...

New results on the oral Alzheimer's pill, valiltramiprosate, claims it can slow down the brain atrophy that causes ...

Tiziana Life Sciences is a buy due to its platform optionality and upcoming catalysts that outweigh its dilution risk and ...

“New-onset anxiety, depression, or irritability in your 60s can be an early and often overlooked sign of Alzheimer’s disease, ...

Richard Oakley of the Alzheimer's Society spoke to Newsweek about why now is an "exciting time" in the battle against the ...

A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...

TORONTO — Health Canada has authorized a drug shown to slow the progression of Alzheimer's disease. Lecanemab is the first ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

Grief affects us all – but not in ways we always consider. People die, yes, but so do pets. We can grieve dreams, jobs, our health, past versions of ourselves. Grief is not linear; it does not come in ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether a patient's memory problems are likely caused by Alzheimer's disease. The new test, called ...

Roche, which currently has investigational Alzheimer’s disease drug trontinemab in phase 3 trials, has secured FDA clearance of its blood-based biomarker test for the condition. The minimally invasive ...